Ledger.Open graph →
SEC Form D · Amendment · filed December 30, 2022

Ashvattha Therapeutics, Inc

Offering
—
Sold
$60.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

George Montgomery · Redwood City, CADirectorJeffrey Cleland · San Carlos, CAExec · DirectorJay Zaveri · Redwood City, CADirectorPalmer Fox · Dover, DEDirectorMelissa A. Mcgrane · Miami, FLExec · DirectorYale J. Baron · New York, NYDirectorYuhang Zhao · Hamden, CTDirectorAhmed D. Wahla · MOUNT KISCO, NYExec · DirectorMarcus L. Collins · West Palm Beach, FLDirectorMarc L. Collins · West Palm Beach, FLDirectorYuhang Zhao · Hamden, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗